Showing results (1991-2000 of 2,327) with videos related to

Sort By:
Pageof 233
Vaccines|March 27, 2026
Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in MiceAlyssa Chalmin Katz, Kevin P Egan, Zauraiz Syeda, et al.
Viruses|July 29, 2023
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1Kevin P Egan, Sita Awasthi, Giulia Tebaldi, et al.
The American Journal of Medicine|October 30, 1987
Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirinG C Bernhard, D J Appelrouth, A D Bankhurst, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1981
Rinkel injection therapy: a multicenter controlled studyS R Hirsch, J H Kalbfleisch, T M Golbert, et al.
Nature Medicine|January 15, 2008
Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responsesMarcio O Lasaro, Nia Tatsis, Scott E Hensley, et al.
The American Journal of Medicine|December 1, 1983
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapyM Brower, D C Ihde, A Johnston-Early, et al.
Psychiatric Research and Clinical Practice|November 4, 2021
A Machine Learning Approach to Predicting New-onset Depression in a Military PopulationLaura Sampson, Tammy Jiang, Jaimie L Gradus, et al.
Fertility and Sterility|October 22, 2008
Variations in serum müllerian inhibiting substance between white, black, and Hispanic womenDavid B Seifer, Elizabeth T Golub, Geralyn Lambert-Messerlian, et al.
The Journal of Nervous and Mental Disease|April 12, 2016
Association of Spirituality With Mental Health Conditions in Ohio National Guard SoldiersStephen J Ganocy, Toyomi Goto, Philip K Chan, et al.
Translational Psychiatry|July 27, 2012
Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathwayG Zimmerman, G Shaltiel, S Barbash, et al.
Pageof 233